As the pharmaceutical industry evolves, serialization and track & trace systems are transitioning from purely regulatory compliance tools to strategic enablers of operational excellence and business growth. This session explores the expanding scope of serialization—from traditional prescription drugs to over-the-counter (OTC) products and cosmetics—highlighting how big pharma and generic companies navigate distinct yet converging roadmaps. Attendees will discover how serialization can be leveraged to enhance supply chain visibility, combat counterfeiting, and integrate with business services across multiple divisions. Further insights will be provided on practical strategies to extend serialization capabilities in preparation for upcoming digital supply chain transformations. In this session, you will learn more about:
- Expanding serialization applications beyond prescription drugs to OTC and cosmetics portfolios.
- Key differences and opportunities in serialization strategies between big pharma and generic manufacturers.
- How to leverage serialized data for operational efficiency, inventory optimization, and enhanced customer engagement.
- Developing a flexible, scalable serialization roadmap aligned with multi-divisional business needs and evolving regulatory landscapes.
&nsbp;